| [1] |
Kenneth Kaushansky.威廉姆斯血液病学[M].北京：人民卫生出版社，2011.
|
| [2] |
Hochhaus A，Larson RA，Guilhot F，et al.Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia[J].N Engl J Med，2017，376（10）：917-927.
|
| [3] |
Geissler J，Sharf G，Bombaci F，et al.Factors influencing adherence in CML and ways to improvement：Results of a patient-driven survey of 2546 patients in 63 countries[J].J Cancer Res Clin Oncol，2017，143（7）：1167-1176.
|
| [4] |
Jabbour EJ，Kantarjian H，Eliasson L，et al.Patient adherence to tyrosine kinase inhibitor therapy in chronic myeloid leukemia[J].Am J Hematol，2012，87（7）：687-691.
|
| [5] |
Rychter A，Jerzmanowski P，Hob A，et al.Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors[J].Med Oncol，2017，34（6）：104.
|
| [6] |
Kekale M，Airaksinen M，Porkka K，et al.Chronic myeloid leukemia patients′ adherence to peroral tyrosine kinase inhibitors compared with adherence as estimated by their physicians[J].Patient Prefer Adherence，2014，8：1619-1627.
|
| [7] |
Hochhaus A，Baccarani M，Silver RT，et al.European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia[J].Leukemia，2020，34（4）：966-984.
|
| [8] |
Poort H，Onghena P，Abrahams HJG，et al.Cognitive Behavioral Therapyfor Treatment-Related Fatiguein Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitors：A Mixed-Method Study[J].J Clin Psychol Med Settings，2019，26（4）：440-448.
|
| [9] |
Zulbaran-Rojas A，Lin HK，Shi Q，et al.A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second-and third-generation tyrosine kinase inhibitors[J].Cancer Med，2018，7（11）：5457-5469.
|
| [10] |
Haque R，Shi J，Chung J，et al.Medication adherence，molecular monitoring，and clinical outcomes in patients with chronic myelogenous leukemia in a large HMO[J].J Am Pharm Assoc（2003），2017，57（3）：303-310.e2.
|
| [11] |
Wang C，Lang J，Xuan L，et al.The effect of health literacy and self-management efficacy on the health-related quality of life of hypertensive patients in a western rural area of China：a cross-sectional study[J].Int J Equity Health，2017，16（1）：58.
|
| [12] |
Xiao X，Wang J，Gu Y，et al.Effect of community based practice of Baduanjin on self-efficacy of adults with cardiovascular diseases[J].PLoS One，2018，13（7）：e0200246.
|
| [13] |
Reed RL，Roeger L，Howard S，et al.A self-management support program for older Australians with multiple chronic conditions：a randomised controlled trial[J].Med J Aust，2018，208（2）：69-74.
|
| [14] |
Kelly C，Grundy S，Lynes D，et al.Self-management for bronchiectasis[J].Cochrane Database Syst Rev，2018，2（2）：CD012528.
|
| [15] |
Wolf TJ，Spiers MJ，Doherty M，et al.The effect of selfmanagement education following mild stroke：an exploratory randomized controlled trial[J].Top Stroke Rehabil，2017，24（5）：345-352.
|
| [16] |
Meslot C，Gauchet A，Hagger MS，et al.A Randomised Controlled Trial to Test the Effectiveness of Planning Strategies to Improve Medication Adherence in Patients with Cardiovascular Disease[J].Appl Psychol Health Well Being，2017，9（1）：106-129.
|
| [17] |
Mcgowan P.The relative effectiveness of self-management programs for type 2 diabetes[J].Can J Diabetes，2015，39（5）：411-419.
|
